# Oral Immunotherapy for Childhood Egg Allergy

> **NCT00461097** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 55 (actual)

## Conditions studied

- Hypersensitivity
- Immediate Hypersensitivity
- Food Hypersensitivity

## Interventions

- **DRUG:** Egg oral immunotherapy
- **DRUG:** Control Group

## Key facts

- **NCT ID:** NCT00461097
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-12
- **Final completion:** 2013-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00461097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00461097, "Oral Immunotherapy for Childhood Egg Allergy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00461097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*